Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus

Maeshima Keisuke; Shibata Hirotaka

首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus

【24h】

Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus

机译：jak 1/2抑制在弥漫性非瘢痕疙瘩治疗中的疗效抑制因全身性狼疮性红斑狼疮治疗

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research 》 |2020年第5期| 共2页
作者
Maeshima Keisuke; Shibata Hirotaka;
展开▼
作者单位

Oita Univ Dept Endocrinol Metab Rheumatol &

Nephrol Fac Med Yufu Japan;

Oita Univ Dept Endocrinol Metab Rheumatol &

Nephrol Fac Med Yufu Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病 ;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus [J] . Maeshima Keisuke, Shibata Hirotaka Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2020 ,第5期

机译：jak 1/2抑制在弥漫性非瘢痕疙瘩治疗中的疗效抑制因全身性狼疮性红斑狼疮治疗
2. Cross-sectional study of hair loss patterns in 122 Korean systemic lupus erythematosus patients: a frequent finding of non-scarring patch alopecia. [J] . Yun SJ, Lee JW, Yoon HJ, The Journal of dermatology . 2007 ,第7期

机译：122名韩国系统性红斑狼疮患者脱发类型的横断面研究：一种非疤痕性斑秃的常见发现。
3. Severe diffuse non-scarring hair loss in systemic lupus erythematosus - Clinical and histopathological analysis of four cases [J] . GongY., YeY., ZhaoY., Journal of the European Academy of Dermatology and Venereology: JEADV . 2013 ,第5期

机译：系统性红斑狼疮严重弥漫性非瘢痕性脱发-4例临床和组织病理学分析
4. Systemic lupus erythematosus: PKCA is an inhibition pathway for mTOR by the active ingredient of green tea [C] . H Mawarti, J Nugraha, D A Purwanto, International Seminar on Smart Molecule of Natural Resources . 2020

机译：Systemic Lupus红斑狼疮：PKCA是由绿茶活性成分的MTOR抑制途径
5. The Influence of Discriminatory Beliefs on Practice: Racial Disparities in the Treatment of Women with Systemic Lupus Erythematosus (SLE) [D] . Armbrister, Adria Natalia. 2014

机译：歧视性信仰对实践的影响：系统性红斑狼疮（SLE）患者治疗中的种族差异
6. Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib [O] . Yu-Lan Chen, Li-Xiong Liu, Qin Huang, 2021

机译：案例报告：由于Tofacitinib治疗后由于Systemic Lupus红斑逆转长期耐火弥漫性非疤痕脱发
7. THE USE OF TOFACITINIB IN THE TREATMENT OF IMMUNE-MEDIATED UNIVERSAL ALOPECIA IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT [O] . Sanna Paula Pires Mariano Campos, Danielle Christinne Soares Egypto de Brito, Thyago Talles de Almeida Santana, 2021

机译：使用TOFACITINIB在系统性红斑狼疮患者中治疗免疫介导的通用脱发：案例报告

Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus

著录项

相似文献

相关主题

期刊订阅